Cryo-Cell International, Inc.CCELNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1.87% | +1.49% | -1.42% | -2.99% | -2.26% |
| Gross Profit Growth | +10.11% | +3.43% | +0.90% | +1.40% | -4.36% |
| EBITDA Growth | +0.00% | +12.91% | -18.37% | +0.00% | -1923.65% |
| Operating Income Growth | +0.00% | +28.59% | +7.27% | +36.74% | +0.00% |
| Net Income Growth | +0.00% | -49.15% | -45.75% | +54.29% | +0.00% |
| EPS Growth | +0.00% | -55.49% | -50.00% | -30.77% | +0.00% |
| EPS Diluted Growth | +0.00% | -55.49% | -50.00% | -30.77% | +0.00% |
| Weighted Average Shares Growth | -2.52% | -2.09% | -0.46% | -0.05% | -0.76% |
| Weighted Average Shares Diluted Growth | -1.54% | -0.67% | -1.29% | -1.22% | -1.75% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -35.50% | +0.00% | -60.13% | +4.08% | -40.62% |
| Free Cash Flow Growth | +47.89% | +0.00% | +0.00% | +17.92% | -39.78% |
| Receivables Growth | +11.14% | +7.21% | +1.46% | -100.00% | -100.00% |
| Inventory Growth | -14.46% | -3.27% | -4.44% | -10.41% | -37.85% |
| Asset Growth | +5.65% | +4.33% | +2.99% | +0.37% | -4.56% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +18.70% | +19.94% | -33.32% | -64.10% | -75.22% |
| R&D Expense Growth | -31.36% | -80.48% | -45.37% | -68.22% | -72.17% |
| SG&A Expenses Growth | +11.45% | +4.74% | +5.88% | -6.59% | -9.35% |